Outcome of treatment of Eichenholtz stage III charcot neuroarthropathy by using bilayer insole: a single center study

Authors

  • Ng Bing Wui Department of Orthopaedics and Traumatology, Faculty of Medicine, University Kebangsaan Malaysia
  • Ohnmar Htwe Rehabilitation Medicine Unit, Department of Orthopaedics and Traumatology, Faculty of Medicine, University Kebangsaan Malaysia
  • Amaramalar Selvi Naicker Rehabilitation Medicine Unit, Department of Orthopaedics and Traumatology, Faculty of Medicine, University Kebangsaan Malaysia
  • Brenda Saria Yuliawiratman Rehabilitation Medicine Unit, Department of Orthopaedics and Traumatology, Faculty of Medicine, University Kebangsaan Malaysia
  • Mohd Yazid Bajuri Department of Orthopaedics and Traumatology, Faculty of Medicine, University Kebangsaan Malaysia
  • Manimalar Selvi Naicker Department of Pathology, Faculty of Medicine, University Malaysia
  • Nurwahidah Abdul Rouf Prosthetic and Orthotic Unit, Department of Medical Rehabilitation Services, Hospital Canselor Tuanku Muhriz Universiti Kebangsha, Malaysia

DOI:

https://doi.org/10.3329/bjms.v20i3.52809

Keywords:

Eichenholtz Stage III; Charcot foot; bilayer Lunairmed insoles; SF-36; AOFAS score

Abstract

Introduction: Insoles are recommended for the treatment of patients with neuropathic foot to distribute the foot plantar pressure while preventing recurrent ulceration. Different types of insole are available but the cost is the major limiting factor. Thus, it is justifiable to conduct this study to evaluate the efficacy of cost effective locally-designed bilayer Lunairmed insoles as an adjunctive treatment for patients with Eichenholtz Stage III Charcot neuroarthropathy in our centre.

Methods: This was a prospective observational study conducted in tertiary centre, Malaysia from September 2016 to September 2017. A total of ten patients with Stage III Charcot neuroarthropathic foot without ankle instability were included. All patients were evaluated for foot plantar pressure by using Tekscan, short form (SF-36) and American Orthopaedic Foot and Ankle Society(AOFAS) score before and after using insoles.

Results: Fifteen out of twenty feet showed reduction in peak plantar pressure (PP) and force-time-integral (FTI) at forefoot and heel after using bilayer Lunairmed insoles. There was a mean reduction of 24.8% of total foot PP.

Conclusion: Locally designed bilayer Lunairmed insoles could be used to reduce PP in Eichenholtz Stage III Charcot neuroarthropathic foot without ankle instability.

Bangladesh Journal of Medical Science Vol.20(3) 2021 p.646-650

Downloads

Download data is not yet available.
Abstract
2
PDF
5

Downloads

Published

2021-04-04

How to Cite

Wui, N. B., Htwe, O., Naicker, A. S., Yuliawiratman, B. S., Bajuri, M. Y., Naicker, M. S., & Rouf, N. A. (2021). Outcome of treatment of Eichenholtz stage III charcot neuroarthropathy by using bilayer insole: a single center study. Bangladesh Journal of Medical Science, 20(3), 646–650. https://doi.org/10.3329/bjms.v20i3.52809

Issue

Section

Case Reports